Caseware UK (AP4) 2023.0.135 2023.0.135 2023-10-312023-10-312022-11-011trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truefalsefalse3 13709058 2022-11-01 2023-10-31 13709058 2021-11-01 2022-10-31 13709058 2023-10-31 13709058 2022-10-31 13709058 c:Director1 2022-11-01 2023-10-31 13709058 d:CurrentFinancialInstruments 2023-10-31 13709058 d:CurrentFinancialInstruments 2022-10-31 13709058 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-31 13709058 d:CurrentFinancialInstruments d:WithinOneYear 2022-10-31 13709058 d:ShareCapital 2023-10-31 13709058 d:ShareCapital 2022-10-31 13709058 d:RetainedEarningsAccumulatedLosses 2023-10-31 13709058 d:RetainedEarningsAccumulatedLosses 2022-10-31 13709058 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-10-31 13709058 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2022-10-31 13709058 c:OrdinaryShareClass1 2022-11-01 2023-10-31 13709058 c:OrdinaryShareClass1 2023-10-31 13709058 c:OrdinaryShareClass1 2022-10-31 13709058 c:FRS102 2022-11-01 2023-10-31 13709058 c:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 13709058 c:FullAccounts 2022-11-01 2023-10-31 13709058 c:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 13709058 e:PoundSterling 2022-11-01 2023-10-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13709058










GREENLEAF SURGICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2023

 
GREENLEAF SURGICAL LIMITED
 
 
  
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF GREENLEAF SURGICAL LIMITED
FOR THE YEAR ENDED 31 OCTOBER 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Greenleaf Surgical Limited for the year ended 31 October 2023 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountantswe are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal .com/uk/en/about-us /regulation/ethics /acca-rulebook.html.

This report is made solely to the director of Greenleaf Surgical Limited in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Greenleaf Surgical Limited and state those matters that we have agreed to state to the director of Greenleaf Surgical Limited in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal .com/content/dam/ACCA_Global /Technical /fact/technical-factsheet -163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Greenleaf Surgical Limited and its director for our work or for this report. 

It is your duty to ensure that Greenleaf Surgical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Greenleaf Surgical Limited. You consider that Greenleaf Surgical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Greenleaf Surgical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Wellers
Accountants
Millweye Court
73 Southern Road
Thame
Oxfordshire
OX9 2ED
19 August 2024
Page 1

 
GREENLEAF SURGICAL LIMITED
REGISTERED NUMBER: 13709058

BALANCE SHEET
AS AT 31 OCTOBER 2023

2023
2022
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
1,196
100

Cash at bank and in hand
 5 
77
-

  
1,273
100

Creditors: amounts falling due within one year
 6 
(28,201)
-

Net current (liabilities)/assets
  
 
 
(26,928)
 
 
100

Total assets less current liabilities
  
(26,928)
100

  

Net (liabilities)/assets
  
(26,928)
100


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(27,028)
-

  
(26,928)
100


Page 2

 
GREENLEAF SURGICAL LIMITED
REGISTERED NUMBER: 13709058
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S Patel
Director

Date: 19 August 2024

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
GREENLEAF SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

1.


General information

Greenleaf Surgical Limited is a private company limited by shares, incorporated in the United Kingdom and registered in England and Wales. The principle place of business is 4 Bessemer Crescent, Rabans Lane Industrial Area, Aylesbury, Bucks, HP19 8TF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the going concern basis which assumes the
company will continue for the foreseeable future. The company have received commercial funding
during the year and are currently working on research and development projects which will result in
a claim for R&D tax credits. Given the nature of the business and the stage of completion of the
projects the going concern basis is deemed appropriate by the directors of the company.

 
2.3

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.

Page 4

 
GREENLEAF SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.5

Pensions

Defined contribution pension plan

The Company contributes to a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
GREENLEAF SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are
Page 6

 
GREENLEAF SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)


2.9
Financial instruments (continued)

discharged or cancelled.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2022 - 1).


4.


Debtors

2023
2022
£
£


Other debtors
1,196
100

1,196
100



5.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
77
-

77
-



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
7,737
-

Amounts owed to associates
10,583
-

Other taxation and social security
3,619
-

Other creditors
4,762
-

Accruals and deferred income
1,500
-

28,201
-


Page 7

 
GREENLEAF SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

7.


Financial instruments

2023
2022
£
£

Financial assets


Financial assets measured at fair value through profit or loss
77
-




Financial assets measured at fair value through profit or loss comprise of cash and cash equivalents.


8.


Share capital

2023
2022
£
£
Allotted, called up and partly paid



100 (2022 - 100) Ordinary shares of £1.00 each
100
100



9.


Pension commitments

The company contributes to a defined contribution pension scheme. The assets of the scheme are held
separately from those of the company in an independantly administered fund. The pension cost charge
represents contributions payable by the Company to the fund and amounted to £234 (2022 - £NIL).
Contributions totalling £100 (2022 - £NIL) were payable to the fund at the balance sheet date.


10.


Related party transactions

At the year end the company has an amount owing to Lynam Pharma Limited, a company of which Mr S Patel is a director of £10,583.


11.


Controlling party

The company was controlled throughout the year by S Patel by virtue of their shareholdings.

 
Page 8